Results 221 to 230 of about 53,302 (297)
Clinical impacts of botulinum toxin type A injections for provoked vestibulodynia: insights from randomized controlled trials. [PDF]
BMC Womens HealthGao Z, Hu L, Yi C, Gao C.
europepmc +1 more source
The use of Botulinum Toxin Type A in patients in out-of-hospital intensive care in Germany-results from a multidisciplinary online survey. [PDF]
Front NeurolOhla V, Groß M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Botulinum Toxin Type A in Dental Medicine
Journal of Dental Research, 2019Botulinum toxins (BoNTs) are a product of the bacteria Clostridium botulinum. By entering nerve endings, they cleave and inactivate SNARE proteins, which are essential for neurotransmitter release. Prevention of acetylcholine release at the neuromuscular junction causes long-lasting and potentially fatal flaccid paralysis—a major feature of botulism ...
V.R.M. Muñoz Lora +3 more
openaire +3 more sources
International Journal of Dermatology, 2021
This study aimed to examine the effectiveness of botulinum toxin type A (BTX‐A) in the treatment of acne.
M. Shirshakova +4 more
semanticscholar +1 more source
This study aimed to examine the effectiveness of botulinum toxin type A (BTX‐A) in the treatment of acne.
M. Shirshakova +4 more
semanticscholar +1 more source
American Heart Journal, 2021
BACKGROUND Post-operative AF (POAF) is the most common complication following cardiac surgery, occurring in 30% to 60% of patients undergoing bypass and/or valve surgery.
J. Piccini +14 more
semanticscholar +1 more source
BACKGROUND Post-operative AF (POAF) is the most common complication following cardiac surgery, occurring in 30% to 60% of patients undergoing bypass and/or valve surgery.
J. Piccini +14 more
semanticscholar +1 more source